Inotiv Inc (NOTV)
4.44
+0.29
(+6.99%)
USD |
NASDAQ |
May 03, 10:58
Inotiv Research and Development Expense (Quarterly)
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2020 | 0.188M |
| June 30, 2020 | 0.105M |
| March 31, 2020 | 0.162M |
| December 31, 2019 | 0.162M |
| September 30, 2019 | 0.23M |
| June 30, 2019 | 0.128M |
| March 31, 2019 | 0.145M |
| December 31, 2018 | 0.124M |
| September 30, 2018 | 0.166M |
| June 30, 2018 | 0.142M |
| March 31, 2018 | 0.149M |
| December 31, 2017 | 0.139M |
| September 30, 2017 | 0.125M |
| June 30, 2017 | 0.127M |
| March 31, 2017 | 0.11M |
| December 31, 2016 | 0.104M |
| September 30, 2016 | 0.104M |
| June 30, 2016 | 0.103M |
| March 31, 2016 | 0.132M |
| December 31, 2015 | 0.157M |
| September 30, 2015 | 0.226M |
| June 30, 2015 | 0.16M |
| March 31, 2015 | 0.138M |
| December 31, 2014 | 0.191M |
| September 30, 2014 | 0.178M |
| Date | Value |
|---|---|
| June 30, 2014 | 0.167M |
| March 31, 2014 | 0.17M |
| December 31, 2013 | 0.143M |
| September 30, 2013 | 0.122M |
| June 30, 2013 | 0.124M |
| March 31, 2013 | 0.123M |
| December 31, 2012 | 0.085M |
| September 30, 2012 | 0.089M |
| June 30, 2012 | 0.113M |
| March 31, 2012 | 0.162M |
| December 31, 2011 | 0.178M |
| September 30, 2011 | 0.184M |
| June 30, 2011 | 0.127M |
| March 31, 2011 | 0.111M |
| December 31, 2010 | 0.112M |
| September 30, 2010 | 0.112M |
| June 30, 2010 | 0.124M |
| March 31, 2010 | 0.138M |
| December 31, 2009 | 0.171M |
| September 30, 2009 | 0.17M |
| June 30, 2009 | 0.174M |
| March 31, 2009 | 0.213M |
| December 31, 2008 | 0.205M |
| September 30, 2008 | 0.198M |
| June 30, 2008 | 0.212M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
0.105M
Minimum
Jun 2020
0.23M
Maximum
Sep 2019
0.1625M
Average
0.162M
Median
Dec 2019
Research and Development Expense (Quarterly) Benchmarks
| Avid Bioservices Inc | -- |
| Macrogenics Inc | 47.35M |
| Synlogic Inc | 10.14M |
| BioXcel Therapeutics Inc | 9.934M |
| IGM Biosciences Inc | 54.19M |